IPA

ImmunoPrecise Antibodies Ltd. (IPA)

About ImmunoPrecise Antibodies Ltd. (IPA)

ImmunoPrecise Antibodies Ltd. is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. It owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. The company was founded by Robert Beecroft on November 22, 1983 and is headquartered in Austin, TX.

Details

Daily high
$0.44
Daily low
$0.40
Price at open
$0.44
52 Week High
$1.39
52 Week Low
$0.27
Market cap
10.9M
Dividend yield
0.00%
Volume
11,214
Avg. volume
471,737
P/E ratio
-.39

ImmunoPrecise Antibodies Ltd. News

Details

Daily high
$0.44
Daily low
$0.40
Price at open
$0.44
52 Week High
$1.39
52 Week Low
$0.27
Market cap
10.9M
Dividend yield
0.00%
Volume
11,214
Avg. volume
471,737
P/E ratio
-.39